Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.068 | 0.7 |
mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |